Stock BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Baxter International Inc.

Equities

BAX

US0718131099

Real-time Estimate Cboe BZX
Other stock markets
 12:09:54 2024-06-10 pm EDT 		5-day change 1st Jan Change
32.86 USD -0.90% Intraday chart for Baxter International Inc. -3.57% -14.99%
Jun. 05 Transcript : Baxter International Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
May. 29 Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
BU
Transcript : Baxter International Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
Ex-dividend day
FA
New Cohort Study Data Shows Baxter's Expanded Hemodialysis, Known as HDx Therapy is associated with approximately 25% Lower Mortality Rate for up to Four Years
AQ
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
BU
Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy
CI
Baxter to Present at Jefferies 2024 Global Healthcare Conference
BU
Citigroup Adjusts Price Target on Baxter International to $38 From $44, Keeps Neutral Rating
MT
Transcript : Baxter International Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
BU
Baxter International's Clinolipid Injection Approved for Expanded Use in US
MT
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
BU
Baxter International Inc. Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
CI
TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40
MT
Declaration of Voting Results by Baxter International Inc
CI
Baxter to Present at Bank of America 2024 Health Care Conference
BU
Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31
MT
Baxter Declares Quarterly Dividend
BU
Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024
CI
UBS Adjusts Price Target on Baxter International to $40 From $42, Maintains Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. News Baxter International Inc.